News > Omicron: India’s genome consortium backtracks on booster dose advice

Omicron: India’s genome consortium backtracks on booster dose advice

Scroll | 05/12/2021 01:57 PM | Click to read full article

The Indian SARS-CoV-2 Genomics Consortium said on Saturday that more scientific experiments are needed to assess the impact of booster doses of Covid-19 vaccines, a week after advising that it may be considered for people above 40 because of the new Omicron virus variant.

Booster shots are jabs given to ramp up the number of antibodies provided by vaccines that wane over a period of time.